This company has been marked as potentially delisted and may not be actively trading. NASDAQ:UBIO ProShares UltraPro Nasdaq Biotechnology (UBIO) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About ProShares UltraPro Nasdaq Biotechnology (NASDAQ:UBIO) 30 days 90 days 365 days Advanced Chart Get UBIO alerts:Sign Up Key Stats Today's Range$17.61▼$17.6150-Day Range$17.61▼$17.7752-Week Range$13.13▼$35.36VolumeN/AAverage Volume42,922 shsMarket Capitalization$14.97 millionAssets Under Management$27.06 millionDividend Yield0.00%Net Expense Ratio0.95%Aggregate RatingN/A ETF Overview Read More ProShares UltraPro Nasdaq Biotechnology ExpensesTypeUBIOHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.75%0.56%0.56%0.54%0.53%Other Expenses0.57%0.47%0.56%0.52%0.56%Total Expense1.32%0.75%0.76%0.73%0.73%Fee Waiver-0.37%-0.67%-0.66%-0.50%-0.63%Net Expense0.95%0.60%0.63%0.63%0.60% Receive UBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProShares UltraPro Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address UBIO ETF News HeadlinesProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.1706June 25, 2025 | msn.comUltraShort Nasdaq Biotechnology declares quarterly distribution of $0.1326March 27, 2025 | msn.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.July 18 at 2:00 AM | Brownstone Research (Ad)Moleculin Biotech Stock (NASDAQ:MBRX) Dividends: History, Yield and DatesDecember 27, 2023 | benzinga.comProShares Trust - ProShares Ultra Nasdaq Cloud Computing (NASDAQ: SKYU)November 6, 2023 | fool.comProShares UltraPro Short Nasdaq BiotechnologyAugust 8, 2023 | thestreet.comSee More Headlines UBIO ETF - Frequently Asked Questions What other stocks do shareholders of ProShares UltraPro Nasdaq Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that ProShares UltraPro Nasdaq Biotechnology investors own include Alibaba Group (BABA), Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESW), Markel Group (MKL), NVIDIA (NVDA), Shopify (SHOP) and Energous (WATT). Fund Details IssuerProShares Fund NameProShares UltraPro NASDAQ Biotechnology Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:UBIO Inception Date6/22/2015 Fund ManagerMichael Neches, Tarak Dave WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNASDAQ Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$27.06 million Average Daily Volume$58.71 thousand Discount/Premium-0.04% Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares850,000BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report UBIO Sector ExposureUBIO Industry Exposure This page (NASDAQ:UBIO) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraPro Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraPro Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
